News
- Author:
- Bruce Jancin
Publish date: July 20, 2018
SAN FRANCISCO – Congressional HEAL Initiative earmarks $250 million over 2 years for pain studies.
News
- Author:
- Bruce Jancin
Publish date: July 19, 2018
NEW ORLEANS – Internist/hospitalist comanagement of total joint arthroplasty patients with orthopedists can impro...
News
- Author:
- Bruce Jancin
Publish date: July 19, 2018
PARIS – Trial challenges conventional thinking about treatment of coronary bifurcation lesions.
News
- Author:
- Bruce Jancin
Publish date: July 18, 2018
MALMO, SWEDEN – “Our results contribute evidence to combat public skepticism, anxiety, fears of adverse events, and possible opposition to HPV vacc...
News
- Author:
- Bruce Jancin
Publish date: July 18, 2018
MALMO, SWEDEN – Recognition of key risk factors warrants early screening ultrasound.
News
- Author:
- Bruce Jancin
Publish date: July 13, 2018
SAN FRANCISCO – The gammaCore device is now FDA-cleared for acute treatment of migraine as well as for episodic c...
News
- Author:
- Bruce Jancin
Publish date: July 13, 2018
MALMO, SWEDEN – HPV type-specific antibody responses are as good or better than in 16- to 26-year-olds who got three ...
News
- Author:
- Bruce Jancin
Publish date: July 13, 2018
SAN FRANCISCO – Sphenopalatine ganglion stimulation, approved in Europe, achieves success in sham-controlled U.S....
News
- Author:
- Bruce Jancin
Publish date: July 11, 2018
PARIS – Large European RCT has shown Firehawk is noninferior to Xience at 1 year.
News
- Author:
- Bruce Jancin
Publish date: July 10, 2018
SAN FRANCISCO – Investigator asks: How can onabotulinumtoxinA possibly still be considered a third- or fourth-line therapy?
News
- Author:
- Bruce Jancin
Publish date: July 5, 2018
SAN FRANCISCO – Chocolate, nitrates, neck pain nixed as major migraine triggers in large study.
News
- Author:
- Bruce Jancin
Publish date: July 5, 2018
SAN FRANCISCO – Sixty percent of migraineurs develop a change in headache pattern during menopausal transition.
News
- Author:
- Bruce Jancin
Publish date: July 2, 2018
PARIS – “Cerebroembolic protection is like a seat belt: You should wear it. All patients should wear it.” – Saibal Kar, MD.
News
- Author:
- Bruce Jancin
Publish date: June 27, 2018
PARIS – “Given the high bleeding risk, single antiplatelet therapy seems to be a good option for these patients,” said Dr. Ulf Landmesser.
News
- Author:
- Bruce Jancin
Publish date: June 25, 2018
PARIS – Hope rides high for novel abluminal DES.
